US FDA Staff Cuts: Biopharma Industry Braces For Impact, But First Wants Clarity On Losses

 
• By Sue Sutter
  
Sand storm
Industry is waiting for the dust to settle on the FDA's staff cuts. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA

More from Agency Leadership